NEW YORK (GenomeWeb) – Canadian life sciences company DiagnoCure yesterday reported that its fourth quarter revenues declined to C$109,831 from C$122,254 year over year on lower royalties tied to its PCA3 biomarker.

The company reported a net loss of C$2.4 million, or C$.05 per share, in the fourth quarter, up sharply from a loss of C$461,710, or C$.01 per share, for Q4 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Scientific American reports that environmental DNA sampling can detect invasive brown marmorated stinkbugs before they've fully invaded a farm.